These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10977443)

  • 1. Hypertension therapy in managed care.
    Tate N; Reed P; Brown P; Gouveia W; Hawkins D; Tifft CP
    Am J Manag Care; 2000 Feb; 6(3 Suppl):S135-7. PubMed ID: 10977443
    [No Abstract]   [Full Text] [Related]  

  • 2. Benazepril approved for treatment of hypertension.
    Clin Pharm; 1991 Oct; 10(10):739. PubMed ID: 1742957
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
    Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
    [No Abstract]   [Full Text] [Related]  

  • 4. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Strauss MH; Weinstein J; Newton GE
    N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation and management of hypertension in children and adolescents (part two): evaluation and management.
    Cromwell PF; Munn N; Zolkowski-Wynne J
    J Pediatr Health Care; 2005; 19(5):309-13. PubMed ID: 16202839
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation on the effect of Benazepril for hypertension through postmarketing surveillance].
    Cao W; Li L; Hu Y; Zhan S; Li X; Li P; Wu T; Li J; Wang T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):190-3. PubMed ID: 11860782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
    Sauer WH; Baer JT; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Nov; 94(9):1171-3. PubMed ID: 15518614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR; Whelton PK;
    N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme inhibitors in the treatment of hypertension in Air Force personnel].
    Godilo-Godlevskiĭ VA; Nagovitsyn AV; Toporishcheva OS; Vovkodav VS
    Voen Med Zh; 2009 May; 330(5):55-7. PubMed ID: 19663210
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Esnault VL
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Increasingly more young infarct patients. Therapy of hypertension leaves room for improvement].
    MMW Fortschr Med; 2002 Dec; 144(50):63. PubMed ID: 14610872
    [No Abstract]   [Full Text] [Related]  

  • 13. [In arterial hypertension: ACE inhibitors and combination therapy].
    Schrader J; Lüders S
    Pharm Unserer Zeit; 2003; 32(1):46-52. PubMed ID: 12577760
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibition in the 1990s and clinical trial results with the new agent benazepril. A symposium. Napa, California, January 25-28, 1990.
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV1-90. PubMed ID: 1680038
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Krut LH
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846227
    [No Abstract]   [Full Text] [Related]  

  • 16. [Control of arterial hypertension in stroke prevention].
    Britov AN; Bystrova MM; Orlov AA
    Klin Med (Mosk); 2002; 80(6):53-7. PubMed ID: 12138805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Pickering TG
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12840099
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Reese AM; Talbert RL; Bussey HI
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846228
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic conversion from fosinopril to benazepril at a Veterans Affairs medical center.
    Gates R; Cookson T; Ito M; Marcus D; Gifford A; Le TN; Nguyen CN
    Am J Health Syst Pharm; 2006 Jun; 63(11):1066-8. PubMed ID: 16709894
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL; Toto RD; McCullough PA
    J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.